Goldfarb Branham Law Firm Pursuing Potential Shareholder Claims Against Clarient Due to Buyout
22 Octubre 2010 - 10:15AM
Business Wire
Goldfarb Branham LLP is investigating whether the Clarient, Inc.
(NASDAQ:CLRT) Board of Directors breached fiduciary duties to
shareholders in connection with the proposed acquisition of the
company by GE Healthcare. If you are a Clarient shareholder you are
encouraged to contact securities lawyer Hamilton Lindley at
877-583-2855 or hlindley@goldfarbbranham.com.
“Clarient will be acquired by GE Healthcare for $5.00 per share
in cash,” said securities lawyer Hamilton Lindley. “However, at
least one analyst has set a price target of $6.00 per share for
Clarient stock. Our proposed class action lawsuit seeks to maximize
the money and information that shareholders can receive under this
transaction.”
Goldfarb Branham LLP has significant experience representing
investors, at no cost to them, in securities lawsuits nationwide.
Firm lawyers have been lead counsel on major securities lawsuits,
including some of the largest transactions in the world and
shareholder litigation stemming from the BP oil spill. Contact
Hamilton Lindley at 877-583-2855 or
hlindley@goldfarbbranham.com.
Clarient, Inc. (MM) (NASDAQ:CLRT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Clarient, Inc. (MM) (NASDAQ:CLRT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Clarient, Inc. (MM) (NASDAQ): 0 recent articles
Más de Goldfarb Branham LLP Artículos de Noticias